<DOC>
	<DOCNO>NCT00881452</DOCNO>
	<brief_summary>The purpose study determine whether CM-AT safe effective treat core symptom autism .</brief_summary>
	<brief_title>A Trial CM-AT Children With Autism</brief_title>
	<detailed_description>Autism currently significant cause disability pediatric population . Treatment base upon observation many child autism digest protein . CM-AT proprietary enzyme design powder take three time day .</detailed_description>
	<mesh_term>Autistic Disorder</mesh_term>
	<criteria>Meets current Diagnostic Statistical Manual Mental Disorders ( DSMIVTR ) diagnostic criterion autistic disorder ( AD ) Patient weigh &lt; 11kg ( 24.2 lb . ) Demonstrated previous allergy porcine ( pork ) product Previous history severe head trauma stroke , seizure within one year enter study uncontrolled systemic disease Diagnosis : HIV , cerebral palsy , endocrine disorder , pancreatic disease Within 30 day start study , certain supplementation , chelation dietary restriction ( 30 day washout period would require inclusion ) Use stimulant medication must discontinue 5 day prior enter study . Subject must stable dose SSRI 's least 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>8 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Autism</keyword>
</DOC>